Cargando…
Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test
BACKGROUND: Combination of multiple biomarkers was an effective strategy to improve sensitivity in cancer diagnosis and screening. However, the performance of the combination of methylated SEPT9 and SDC2 for detection of colorectal cancer (CRC) has yet to be reported. METHODS: A new qPCR-based assay...
Autores principales: | Chen, Ying, Wang, Zhenzhen, Zhao, Guodong, Sun, Chuang, Ma, Yong, Zhang, Linyan, Zheng, Minxue, Li, Hongchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476029/ https://www.ncbi.nlm.nih.gov/pubmed/31089394 http://dx.doi.org/10.1155/2019/5232780 |
Ejemplares similares
-
Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection
por: Chen, Zhiliang, et al.
Publicado: (2021) -
Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
por: Zhao, Guodong, et al.
Publicado: (2019) -
Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
por: Zhu, Yunfeng, et al.
Publicado: (2022) -
Neuropeptide reporter assay for serum, capillary blood and blood cards
por: Schreiber, U., et al.
Publicado: (2020) -
Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)